GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Gross-Profit-to-Asset %

Realcan Pharmaceutical Group Co (SZSE:002589) Gross-Profit-to-Asset % : 6.39% (As of Sep. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Realcan Pharmaceutical Group Co's annualized Gross Profit for the quarter that ended in Sep. 2023 was ¥1,141 Mil. Realcan Pharmaceutical Group Co's average Total Assets over the quarter that ended in Sep. 2023 was ¥17,854 Mil. Therefore, Realcan Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 6.39%.


Realcan Pharmaceutical Group Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Gross-Profit-to-Asset % Chart

Realcan Pharmaceutical Group Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.00 20.25 15.49 13.11 7.48

Realcan Pharmaceutical Group Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.24 -3.00 6.82 4.56 6.39

Competitive Comparison of Realcan Pharmaceutical Group Co's Gross-Profit-to-Asset %

For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Realcan Pharmaceutical Group Co's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Realcan Pharmaceutical Group Co's Gross-Profit-to-Asset % falls into.



Realcan Pharmaceutical Group Co Gross-Profit-to-Asset % Calculation

Realcan Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=1672.075/( (26396.974+18331.075)/ 2 )
=1672.075/22364.0245
=7.48 %

Realcan Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=1141.092/( (18281.21+17427.545)/ 2 )
=1141.092/17854.3775
=6.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Realcan Pharmaceutical Group Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Traded in Other Exchanges
N/A
Address
No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines